Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valemetostat tosylate is a dual inhibitor of EZH1/2 and used in the research of relapsed/refractory peripheral T-cell lymphoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 916.00 | |
50 mg | 6-8 weeks | $ 1,190.00 | |
100 mg | 6-8 weeks | $ 1,650.00 |
Description | Valemetostat tosylate is a dual inhibitor of EZH1/2 and used in the research of relapsed/refractory peripheral T-cell lymphoma. |
Synonyms | DS-3201 tosylate |
Molecular Weight | 660.22 |
Formula | C33H42ClN3O7S |
CAS No. | 1809336-93-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (189.33 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Valemetostat tosylate 1809336-93-3 Chromatin/Epigenetic Histone Methyltransferase Valemetostat Tosylate DS-3201 Tosylate DS-3201 tosylate DS 3201 Tosylate DS3201 Tosylate inhibitor inhibit